BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19140229)

  • 1. Transient and etiology-related transcription regulation in cirrhosis prior to hepatocellular carcinoma occurrence.
    Caillot F; Derambure C; Bioulac-Sage P; Francois A; Scotte M; Goria O; Hiron M; Daveau M; Salier JP
    World J Gastroenterol; 2009 Jan; 15(3):300-9. PubMed ID: 19140229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide differences in hepatitis C- vs alcoholism-associated hepatocellular carcinoma.
    Derambure C; Coulouarn C; Caillot F; Daveau R; Hiron M; Scotte M; Francois A; Duclos C; Goria O; Gueudin M; Cavard C; Terris B; Daveau M; Salier JP
    World J Gastroenterol; 2008 Mar; 14(11):1749-58. PubMed ID: 18350606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: transplant implications.
    Behnke MK; Reimers M; Fisher RA
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):45-53. PubMed ID: 24378265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients.
    Shao RX; Hoshida Y; Otsuka M; Kato N; Tateishi R; Teratani T; Shiina S; Taniguchi H; Moriyama M; Kawabe T; Omata M
    World J Gastroenterol; 2005 Apr; 11(13):1995-9. PubMed ID: 15800993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma.
    Lendvai G; Szekerczés T; Gyöngyösi B; Schlachter K; Kontsek E; Pesti A; Patonai A; Werling K; Kovalszky I; Schaff Z; Kiss A
    Pathol Oncol Res; 2019 Jul; 25(3):1103-1109. PubMed ID: 30411298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulated expression of the TSAP6 protein in liver is associated with a transition from cirrhosis to hepatocellular carcinoma.
    Caillot F; Daveau R; Daveau M; Lubrano J; Saint-Auret G; Hiron M; Goria O; Scotte M; Francois A; Salier JP
    Histopathology; 2009 Feb; 54(3):319-27. PubMed ID: 19236508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXP1 and SPINK1 reflect the risk of cirrhosis progression to HCC with HBV infection.
    Li F; Liu T; Xiao CY; Yu JX; Lu LG; Xu MY
    Biomed Pharmacother; 2015 May; 72():103-8. PubMed ID: 26054682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predication analysis of microarray data to determine altered gene profiles in liver carcinoma related to HBV-related cirrhosis].
    Liu J; Zhang Q; Li Z; Zhang Q; Qu Y; Lu L; Xu M
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):625-30. PubMed ID: 25243966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
    Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.
    Mas VR; Maluf DG; Archer KJ; Yanek K; Kong X; Kulik L; Freise CE; Olthoff KM; Ghobrial RM; McIver P; Fisher R
    Mol Med; 2009; 15(3-4):85-94. PubMed ID: 19098997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver expression of Nrf2-related genes in different liver diseases.
    Cheng ML; Lu YF; Chen H; Shen ZY; Liu J
    Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):485-91. PubMed ID: 26459724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and topological properties in hepatocellular carcinoma transcriptome.
    Drozdov I; Bornschein J; Wex T; Valeyev NV; Tsoka S; Malfertheiner P
    PLoS One; 2012; 7(4):e35510. PubMed ID: 22539975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
    Kanda T; Goto T; Hirotsu Y; Moriyama M; Omata M
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated molecular signature in the tissue samples of patients with cirrhosis.
    Kim JW; Ye Q; Forgues M; Chen Y; Budhu A; Sime J; Hofseth LJ; Kaul R; Wang XW
    Hepatology; 2004 Feb; 39(2):518-27. PubMed ID: 14768006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
    Liu X; Wang SK; Zhang K; Zhang H; Pan Q; Liu Z; Pan H; Xue L; Yen Y; Chu PG
    Carcinogenesis; 2015 Feb; 36(2):232-42. PubMed ID: 25542894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.